184 related articles for article (PubMed ID: 1662127)
1. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
Mattina R; Bonfiglio G; Cocuzza CE; Gulisano G; Cesana M; Imbimbo BP
Chemotherapy; 1991; 37(6):389-97. PubMed ID: 1662127
[TBL] [Abstract][Full Text] [Related]
2. Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
Triger DR; Granai F; Woodcock J; Wise R; Imbimbo BP
Hepatology; 1993 Oct; 18(4):847-52. PubMed ID: 8406358
[TBL] [Abstract][Full Text] [Related]
3. Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
Kisicki JC; Griess RS; Ott CL; Cohen GM; McCormack RJ; Troetel WM; Imbimbo BP
Antimicrob Agents Chemother; 1992 Jun; 36(6):1296-301. PubMed ID: 1329618
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tissue penetration of rufloxacin, a long acting quinolone antimicrobial agent.
Wise R; Johnson J; O'Sullivan N; Andrews JM; Imbimbo BP
J Antimicrob Chemother; 1991 Dec; 28(6):905-9. PubMed ID: 1667783
[TBL] [Abstract][Full Text] [Related]
5. Biliary excretion of rufloxacin in humans.
Privitera G; Nicastro G; Imbimbo BP; Cesana M; Visconti M; Lombardi F; Tagliabue G; Faleschini E; Colturani F; Franzini P
Antimicrob Agents Chemother; 1993 Dec; 37(12):2545-9. PubMed ID: 8109915
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of rufloxacin in healthy volunteers.
Segre G; Cerretani D; Moltoni L; Urso R
Eur J Clin Pharmacol; 1992; 42(1):101-5. PubMed ID: 1311685
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
[TBL] [Abstract][Full Text] [Related]
8. Steady-state pharmacokinetics of rufloxacin in elderly patients with lower respiratory tract infections.
Cogo R; Rimoldi R; Mattina R; Imbimbo BP
Ther Drug Monit; 1992 Feb; 14(1):36-41. PubMed ID: 1312263
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of rufloxacin once daily in patients with lower respiratory tract infections.
Rimoldi R; Fioretti M; Albrici A; Imbimbo BP
Infection; 1992; 20(2):89-93. PubMed ID: 1316313
[TBL] [Abstract][Full Text] [Related]
10. Inter- and intrasubject variabilities in the pharmacokinetics of rufloxacin after single oral administration to healthy volunteers.
Imbimbo BP; Broccali G; Cesana M; Crema F; Attardo-Parrinello G
Antimicrob Agents Chemother; 1991 Feb; 35(2):390-3. PubMed ID: 2024974
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of temafloxacin in humans after multiple oral doses.
Granneman GR; Carpentier P; Morrison PJ; Pernet AG
Antimicrob Agents Chemother; 1992 Feb; 36(2):378-86. PubMed ID: 1318680
[TBL] [Abstract][Full Text] [Related]
12. Ocular pharmacokinetics of rufloxacin a new fluoroquinolone antibiotic.
Nucci P; Lombardo N; Cremonesi F; Manitto MP; Brancato R; Ghione M
Clin Ter; 1992 Jun; 140(6):563-7. PubMed ID: 1322259
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
Giguère S; Sweeney RW; Bélanger M
Am J Vet Res; 1996 Jul; 57(7):1025-30. PubMed ID: 8807015
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of rufloxacin in patients with impaired renal function.
Perry G; Mant TG; Morrison PJ; Sacks S; Woodcook J; Wise R; Imbimbo BP
Antimicrob Agents Chemother; 1993 Apr; 37(4):637-41. PubMed ID: 8388194
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
Nakashima M; Uematsu T; Kosuge K; Umemura K; Hakusui H; Tanaka M
Antimicrob Agents Chemother; 1995 Jan; 39(1):170-4. PubMed ID: 7695301
[TBL] [Abstract][Full Text] [Related]
16. Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.
Ritz M; Lode H; Fassbender M; Borner K; Koeppe P; Nord CE
Antimicrob Agents Chemother; 1994 Mar; 38(3):455-9. PubMed ID: 8203837
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of enrofloxacin in fingerling rainbow trout (Oncorhynchus mykiss).
Bowser PR; Wooster GA; St Leger J; Babish JG
J Vet Pharmacol Ther; 1992 Mar; 15(1):62-71. PubMed ID: 1315398
[TBL] [Abstract][Full Text] [Related]
18. Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin.
Lazzaroni M; Imbimbo BP; Bargiggia S; Sangaletti O; Dal Bo L; Broccali G; Bianchi Porro G
Antimicrob Agents Chemother; 1993 Oct; 37(10):2212-6. PubMed ID: 8257146
[TBL] [Abstract][Full Text] [Related]
19. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
Bron NJ; Dorr MB; Mant TG; Webb CL; Vassos AB
J Antimicrob Chemother; 1996 Dec; 38(6):1023-9. PubMed ID: 9023649
[TBL] [Abstract][Full Text] [Related]
20. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
